News

As part of the settlement, Abaxis will receive $17.25m from Cepheid and withdraw all pending litigation claims. Abaxis CEO and chairman Clint Severson said the agreement will allow

The added enhancements are available across all MedeAnalytics solutions and require no upgrades or installations to access them, according to the company. MedeAnalytic product management vice president Christian

RayBiotech will leverage the reagents and technologies to expand its antibody-based products and services platforms. The financial terms of the agreement were kept confidential. Commenting on the license,

The inspection involved a MHRA inspector who evaluated the facility and concluded that the site has no critical or major failures and continues to be compliant with EU

The companies are working to smoothly shift activities and make sure the continuous availability of the product in approved countries. Merck Research Laboratories atherosclerosis and cardiovascular research senior

Under the agreement, Philip Morris will use Medicago’s technologies and VLPs for developing, manufacturing Medicago’s pandemic and seasonal influenza vaccines in china. The terms of Philip Morris’ deal

AEZS-130 patent came into effect from 19 September 2012 and will be valid till 19 February 2027. Aeterna Zentaris president and CEO Juergen Engel said the patent in

Pervenio Lung RS is also expected to meet prognostic information needed to guide preventative treatment and improve disease management. The test consists of a quantitative PCR (polymerase chain

The FDA has not granted orphan drug exclusivity to Gralise, even though the product was approved for orphan drug designation in November 2010 for the management of PHN